EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Morbidity and Oncological Outcome After Curative Treatment in Sinonasal Squamous Cell Carcinoma

Ralph Hohenberger iD, Sven Beckmann, Christoph Kaecker, Olgun Elicin, Roland Giger, Marco Caversaccio, Lukas Anschuetz

Ear, Nose & Throat Journal · 2025-06 · 104 (6)

DOI: 10.1177/01455613221117787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ear, Nose & Throat Journal, online erschienen am 06.08.2022. Verfasst von Ralph Hohenberger und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Paranasal Sinus Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Sinonasal squamous cell carcinomas are rare and aggressive tumors. Curative therapy includes surgery and radiotherapy, with high risk for local morbidity and impaired quality of life. The objective of this study was to analyze a large cohort of patients with sinonasal squamous cell carcinoma on treatment morbidity and oncological outcome.

Methods

Patients with sinonasal squamous cell carcinoma (n = 75) treated at a tertiary referral center between 2008 and 2019 were identified. In patients with curative treatment intent (n = 70), a chart review and analysis on patient and tumor characteristics, morbidity, and oncological outcome was performed.

Results

Mean follow-up was 59 months. Primary curative therapy was surgery alone (n = 18), surgery with radiation (n = 25), and primary (chemo)radiation (n = 27). Forty-two (60%) patients suffered from treatment-related morbidity; most frequent symptoms were dry nasal mucosa (20%), nasal obstruction (14.3%), and vision impairment or loss (11.5%). Patients with early disease had less morbidity (51.4 vs 71.1%; P = 0.09), a lower recurrence rate (27% vs. 48.5%; P = 0.08), and better overall survival (92.5% vs. 71.1%; P = 0.01).

Conclusion

Treatment-related morbidity is common after curative treatment of sinonasal squamous cell carcinomas. Early disease is beneficial in terms of occurrence and severity as multimodal treatment and recurrence can more likely be avoided.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellParanasal Sinus NeoplasmsHumansMaleFemaleMiddle AgedAgedTreatment OutcomeRetrospective StudiesNeoplasm Recurrence, LocalAdultAged, 80 and overCombined Modality TherapyMorbidityQuality of Life

Stichwörter der Autor:innen

endoscopic sinus surgeryendoscopyhead and neckquality of liferhinologysquamous cell carcinoma

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

ORCID-Profile: Ralph Hohenberger

Zitieren

APA

Hohenberger, R., Beckmann, S., Kaecker, C., Elicin, O., Giger, R., Caversaccio, M., & Anschuetz, L. (2025). Morbidity and Oncological Outcome After Curative Treatment in Sinonasal Squamous Cell Carcinoma. Ear, Nose & Throat Journal, 104(6). https://doi.org/10.1177/01455613221117787

Vancouver

Hohenberger R, Beckmann S, Kaecker C, Elicin O, Giger R, Caversaccio M, et al. Morbidity and Oncological Outcome After Curative Treatment in Sinonasal Squamous Cell Carcinoma. Ear, Nose & Throat Journal. 2025;104(6). doi:10.1177/01455613221117787

BibTeX
@article{Hohenberger2025,
  author = {Hohenberger, Ralph and Beckmann, Sven and Kaecker, Christoph and Elicin, Olgun and Giger, Roland and Caversaccio, Marco and Anschuetz, Lukas},
  title = {Morbidity and Oncological Outcome After Curative Treatment in Sinonasal Squamous Cell Carcinoma},
  journal = {Ear, Nose & Throat Journal},
  year = {2025},
  volume = {104},
  number = {6},
  doi = {10.1177/01455613221117787}
}
Kostenlos starten →